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Purpose or Objective: The dose variation of stereotactic 
body radiation therapy using volumetric modulated arc 
therapy (VMAT SBRT) for lung cancer varies due to the 
interplay effect between multileaf collimator (MLC) motion 
and tumor motion. The aim of this study was to assess the 
relationship between dose variation and factors related to 
the interplay effect and clarify optimal conditions for VMAT 
SBRT. 
 
Material and Methods: Respiratory motion data and MLC 
motion data were obtained from 30 patients who underwent 
treatment with VMAT SBRT for lung cancer. We calculated 
number of breaths (NB) during irradiation, maximum 
craniocaudal tumor motion (Amp), and MLC motion 
complexity (MCSv, modulation complexity score applied to 
VMAT). Parameters assessed for each treatment plan were 
MCSv, a divisor combination of Amp and MCSv (AmpMCSv), 
and a multiplier combination of AmpMCSv and NB (IVS, 
interplay effect variable score). Static and dynamic 
measurements were performed with a PinPoint chamber 
(0.015cm3, PTW, Germany) in a Quasar phantom (Modus 
Medical Devices, Canada). Pearson's correlation analysis was 
used to assess the effect of dose variation on individual 
parameters. 
 
Results: A wide range of NB (28.9 to 100.7 times) was 
observed. The standard deviation of dynamic measurement 
ranged from 1.3 to 12.5 cGy. Dose variation was negatively 
correlated with AmpMCSv (r = −0.52, p < 0.05) and IVS (r = 
−0.62, p < 0.05). IVS was obtained stronger correlation than 
AmpMCSv by considering NB. Significant dose variation was 
found in cases with the lowest NB (28.9 times). 
 
 
 
Conclusion: Patients that had fewer than 40 NB, <150 s 
irradiation time, and a respiratory cycle of >4 s had the 
highest dose variation, and therefore required careful 
attention during VMAT SBRT treatment. 
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Purpose or Objective: To investigate intra-fraction breast 
motion during long-lasting (10-20 min) breast Helical 
Tomotherapy (Accuray, Madison, WI, USA) by means of 
optical tracking. 
 
Material and Methods: Twenty locoregional breast cancer 
patients underwent Helical Tomotherapy irradiation after 
receiving conservative surgery or mastectomy. Non-invasive 
monitoring of respiratory motion during the entire treatment 
course, from setup verification to dose delivery, was 
achieved through infrared tracking of a passive marker 
placed near the surgical scar. In order to obtain the 
displacement deriving from the patient movement only, we 
subtracted the trace of an additional marker placed on the 
treatment couch. Respiratory signals were analyzed in terms 
of peak-to-peak amplitudes and baseline drifts, obtained by 
low-pass moving average filtering with a time window of 60 
sec. Anisotropic Clinical Target Volume (CTV) safety margins 
expansion due to intrafraction organ motion was calculated 
relying on a synthetic representation of the specific patient 
respiratory pattern, obtained by adding half of the most 
probable respiratory amplitude to the non-respiratory 
movement of the scar trace in each anatomical direction 
(Fig.1).  
 
 
 
Results: The most probable measured breathing amplitudes 
among all patients was (median±inter-quartile range): 
0.25±0.12 mm (right-left), 1.31±0.63mm (inferior-superior) 
and 1.22±0.70 mm (posterior-anterior). Each patient featured 
a small inter-fraction variability of expected motion ranges, 
thus confirming a good reproducibility of respiratory motion 
during the entire course of treatment. Scar baseline drifts 
were mostly in posterior and in the inferior direction for all 
patients in most fractions, with the exception of patient P2, 
who exhibited a relevant baseline shift in superior and 
anterior direction with a large variability (Tab.1). The 
distribution of right-left shifts resulted in almost zero 
median, with a narrow interquartile range. Patient P20 
showed stationary breathing, with a median baseline shift 
around zero in all anatomical directions. Conversely, patient 
P15 had a wide inferior-superior and posterior-anterior 
motion with large interquartile ranges. Resulting anisotropic 
safety margin expansions across all patients with the 
exception of P2, considered an outlier, were 1.58-2.44 mm in 
right-left, 4.41-3.65 mm in inferior-superior and 3.78-2.15 
mm in the posterior-anterior directions, respectively.  
